Navigation Links
New Agreements Underscore QIAGEN's Leadership in Bioinformatics
Date:2/2/2016

HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ --

FDA centers and researchers gain access to QIAGEN's enhanced solutions for applications including microbial and microbiome analysis

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the use of its market leading bioinformatics solutions for microbiome, metagenomics and other applications.

QIAGEN Bioinformatics signed an agreement with genomics big data company CosmosID, Inc. to allow users of QIAGEN's CLC Genomics Workbench to access and integrate CosmosID's metagenomics analysis platform into their QIAGEN bioinformatics platform. CosmosID's platform allows users to identify and characterize microbial communities from whole genome shotgun data and to determine their relative abundance. The new plug-in expands the range of metagenomic and microbiome applications supported by QIAGEN's microbial genomics solution enabling researchers in fields such as infectious disease, animal health, agriculture, environmental and food safety to use shotgun metagenomics analysis for routine testing employing next-generation sequencing.

Click here for full press release

Public Relations:
Dr. Thomas Theuringer
Director Public Relations
+49-2103-29-11826
+1-240-686-7425
Email: pr@qiagen.com
http://www.twitter.com/qiagen
https://www.facebook.com/QIAGEN
pr.qiagen.com

Investor Relations:
John Gilardi
Vice President Corporate Communications and Investor Relations
+49-2103-29-11711
+1-240-686-2222
Email: ir@qiagen.com


'/>"/>
SOURCE QIAGEN NV
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. QIAGEN Reaches Milestone With Portfolio of Master Collaboration Agreements for Pharma Companion Diagnostics
2. Agreements & Partnerships, a Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Oncology Information System Market - MarketsandMarkets
3. Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)
4. Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5. Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech, and Diagnostics
6. A Revelation on Asset Purchase Terms and Agreements in Pharma, Biotech, and Diagnostics
7. Molecular Diagnostics Partnering Terms and Agreements : Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz
8. Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us
9. Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
10. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
11. Sanguine BioSciences Signs Agreements with More than 200 Partners to Enable Efficient Personalized Medicine Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2019)... ... 20, 2019 , ... Murrieta Genomics , the genomic ... growing NGS (Next Generation Sequencing) field, have announced a partnership to bring fast ... an innovation center and idea incubator, we are always looking for new applications ...
(Date:2/22/2019)... CHICAGO (PRWEB) , ... February 20, 2019 , ... ... six patents related to Novel Captcha Systems. , The patents in ... processes. Visual patterns and tests are used to distinguish between human users and ...
(Date:2/16/2019)... TORONTO (PRWEB) , ... February 14, 2019 , ... ... data visualization, analytics, and knowledge sharing capability that also provides the flexibility for ... and play” functionality. It also provides a shared workbench to conduct quick analytics ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... finalized a deal to extend their use of Medrio, the leading provider of ... The CRO has been a regular Medrio customer for over nine years, primarily ...
Breaking Biology Technology:
(Date:3/9/2019)... ... March 07, 2019 , ... A firm believer in causes greater than ... Society (LLS). This donation will help fund not only research to find a cure, ... , “We are always on the lookout for ways to make a difference. When ...
(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio announces ... exciting compounds for scientists studying GPCR and DREADD signalling. Hello Bio has been ... Institute of Neurological Disorders and Stroke, both institutes of the National Institutes of ...
(Date:2/27/2019)... ... , ... Fluxion Biosciences, a leading developer of precision solutions for life science ... for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant will ... Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to improve ...
Breaking Biology News(10 mins):